Clinical Trials Directory

Trials / Completed

CompletedNCT04300751

The Behavioral Effects of Opioids and Alcohol

Interactions of Alcohol and Opioids: Pharmacodynamic Effects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Sharon Walsh · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study will examine the effects of doses of alcohol/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction effects of these compounds.

Conditions

Interventions

TypeNameDescription
DRUGAlcoholActive alcohol or placebo, administered orally
DRUGOpioid AgonistActive opioid agonist or placebo, administered orally

Timeline

Start date
2021-03-24
Primary completion
2024-11-09
Completion
2024-11-09
First posted
2020-03-09
Last updated
2025-11-20
Results posted
2025-11-20

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04300751. Inclusion in this directory is not an endorsement.

The Behavioral Effects of Opioids and Alcohol (NCT04300751) · Clinical Trials Directory